Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Abstract Background Sodium-glucose co-transporter-2 (SGLT2) inhibitors improve outcomes among patients with established heart failure. Despite supportive basic science studies, there are no data...

Supriya Shore,...